PMID- 31955909 OWN - NLM STAT- MEDLINE DCOM- 20210111 LR - 20210111 IS - 1618-0372 (Electronic) IS - 0065-1281 (Linking) VI - 122 IP - 3 DP - 2020 Apr TI - Differences in the expression of catecholamine-synthesizing enzymes between vesicular monoamine transporter 1- and 2-immunoreactive glomus cells in the rat carotid body. PG - 151507 LID - S0065-1281(20)30006-4 [pii] LID - 10.1016/j.acthis.2020.151507 [doi] AB - Vesicular monoamine transporters (VMAT) 1 and 2 are responsible for monoamine transportation into secretary vesicles and are tissue-specifically expressed in central and peripheral monoaminergic tissues, including the carotid body (CB). The aim of the present study was to examine the expression of catecholamine-synthesizing enzymes in VMAT1- and VMAT2-immunoreactive glomus cells in the rat CB using multiple immunolabeling. The expression of VMAT1 and VMAT2 mRNA in the CB was confirmed by RT-PCR. Immunohistochemistry revealed that VMAT1 immunoreactivity was predominant in glomus cells rather than VMAT2 immunoreactivity. Glomus cells with VMAT1 immunoreactivity exhibited weak/negative VMAT2 immunoreactivity, and vice versa. Immunoreactivities for VMAT1 and tyrosine hydroxylase, the rate-limiting enzyme for catecholamine biosynthesis, were co-localized in the same glomus cells and a positive correlation was confirmed between the two immunoreactivities (Spearman's coefficient = 0.82; p <  0.05). Although some glomus cells showed co-localization of VMAT2 and dopamine beta-hydroxylase immunoreactivity, the biosynthetic enzyme for noradrenaline, VMAT2 immunoreactivity appeared to be less associated with both catecholamine-synthesizing enzymes as indicated by a correlation analysis (TH: Spearman's coefficient = 0.38, DBH: Spearman's coefficient = 0.26). These results indicate that heterogeneity on functional role would exist among glomus cells in terms of VMAT isoform and catecholamine-synthesizing enzymes expression. CI - Copyright (c) 2020 Elsevier GmbH. All rights reserved. FAU - Kato, Kouki AU - Kato K AD - Center for Laboratory Animal Science, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan. FAU - Yokoyama, Takuya AU - Yokoyama T AD - Department of Anatomy (Cell Biology), Iwate Medical University, 2-1-1 Nishitokuta, Yahaba, Iwate 028-3694, Japan. FAU - Kusakabe, Tatsumi AU - Kusakabe T AD - Laboratory for Anatomy and Physiology, Department of Sport and Medical Science, Kokushikan University, 7-3-1 Nagayama, Tama, Tokyo 206-8515, Japan. FAU - Hata, Katsuhiko AU - Hata K AD - Laboratory for Anatomy and Physiology, Department of Sport and Medical Science, Kokushikan University, 7-3-1 Nagayama, Tama, Tokyo 206-8515, Japan. FAU - Fushuku, Seigo AU - Fushuku S AD - Center for Laboratory Animal Science, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan. FAU - Nakamuta, Nobuaki AU - Nakamuta N AD - Laboratory of Veterinary Anatomy and Cell Biology, Faculty of Agriculture, Iwate University, 3-18-8 Ueda, Morioka, Iwate 020-8550, Japan. FAU - Yamamoto, Yoshio AU - Yamamoto Y AD - Laboratory of Veterinary Anatomy and Cell Biology, Faculty of Agriculture, Iwate University, 3-18-8 Ueda, Morioka, Iwate 020-8550, Japan. Electronic address: yyoshio@iwate-u.ac.jp. LA - eng PT - Journal Article DEP - 20200116 PL - Germany TA - Acta Histochem JT - Acta histochemica JID - 0370320 RN - 0 (Catecholamines) RN - 0 (RNA, Messenger) RN - 0 (Slc18a1 protein, rat) RN - 0 (Slc18a2 protein, rat) RN - 0 (Vesicular Monoamine Transport Proteins) RN - EC 1.14.17.1 (Dopamine beta-Hydroxylase) RN - X4W3ENH1CV (Norepinephrine) SB - IM MH - Animals MH - Carotid Body/cytology/*metabolism MH - Catecholamines/*biosynthesis MH - Dopamine beta-Hydroxylase/metabolism MH - Immunohistochemistry MH - Male MH - Norepinephrine/biosynthesis MH - RNA, Messenger/biosynthesis/genetics MH - Rats MH - Rats, Wistar MH - Vesicular Monoamine Transport Proteins/genetics/*metabolism OTO - NOTNLM OT - Carotid body OT - Dopamine OT - Glomus cell OT - Immunohistochemistry OT - Noradrenaline OT - Vesicular monoamine transporter COIS- Declaration of Competing Interest The authors declare that they have no conflict of interest. EDAT- 2020/01/21 06:00 MHDA- 2021/01/12 06:00 CRDT- 2020/01/21 06:00 PHST- 2019/09/08 00:00 [received] PHST- 2019/12/06 00:00 [revised] PHST- 2019/12/27 00:00 [accepted] PHST- 2020/01/21 06:00 [pubmed] PHST- 2021/01/12 06:00 [medline] PHST- 2020/01/21 06:00 [entrez] AID - S0065-1281(20)30006-4 [pii] AID - 10.1016/j.acthis.2020.151507 [doi] PST - ppublish SO - Acta Histochem. 2020 Apr;122(3):151507. doi: 10.1016/j.acthis.2020.151507. Epub 2020 Jan 16.